OncoCyte Corp
IRVINE, California, United States · Biotechnology, Genetics, Health Care
Oncocyte™ is a precision diagnostics company with a mission to improve patient outcomes by providing personalized insights that inform critical decisions throughout the patient care journey.
Key facts
- Headquarters
- IRVINE, California, United States
- Employees
- 56
- Industries
- Biotechnology, Genetics, Health Care
- Status
- Public (IMDX)
- Website
- oncocyte.com
- Company page
Recent activity at OncoCyte Corp
- : SEC 8-K (2.02): On May 13, 2026, Insight Molecular Diagnostics Inc. announced its financial results for the three months ended March 31, 2026. The press release outlines the company's performance metrics, including revenues and earnings figures for the first quarter, providing insights into the company's operational effectiveness and market position. This event is significant as it informs shareholders and potential investors about the company’s financial health and future prospects, emphasizing transparency and adherence to regulatory standards. The details are included in the press release furnished as Exhibit 99.1.
- : SEC 8-K (1.01): On February 10, 2026, Insight Molecular Diagnostics Inc. entered into securities purchase agreements with institutional investors for a registered direct offering. The Company agreed to issue and sell 3,482,498 shares of its common stock at an offering price of $5.75 per share, and Pre-Funded Warrants to purchase up to 1,043,478 additional shares at a price of $5.7499 per warrant. This transaction is backed by an effective shelf registration statement and is expected to enhance the Company's capital for growth initiatives.
- : Oncocyte
- : Oncocyte Corp. Launches VitaGraft™ Kidney to Enhance Monitoring of Kidney Transplant Patients
- : Oncocyte
- : Oncocyte Corporation Announces $10.2 Million Private Placement of Securities
- : Oncocyte Corporation Appoints Andrea James as Chief Financial Officer and Principal Financial Officer
- : Oncocyte
- : OncoCyte Corp
- : OncoCyte Corp
OncoCyte Corp funding history
| Date | Round | Amount |
|---|---|---|
| Feb 2025 | Venture | $21.7M |
| Oct 2024 | Venture | $10.2M |
| Apr 2024 | Venture | $15.8M |
| Apr 2021 | Seed | $3.0M |
| Mar 2021 | Venture | $5.0M |
Leadership
- Ronald Andrews, Executive Officer, Director
- Cavan Redmond, Director
- Jennifer Carter, Director
- Melinda Griffith, Director
- Andy Arno, Director
- Alfred Kingsley, Director
- Andrew Last, Director
- Andrea James, Chief Financial Officer
- Johnson Chiang, Chief Technology Officer
- Josh Riggs, Chief Executive Officer
- Mitchell Levine, Executive Officer
- Douglas Ross, Executive Officer
Verified email and direct lines for OncoCyte Corp’s decision-makers are on Fundz. See plans
Employee benefit plans
OncoCyte Corp files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
OncoCyte Corp in the news
- Renal Oncocytic Neoplasms: Review of Classification Updates, Imaging, and Management - RSNA Journals (Jun 08, 2026)
- OncoCyte Corp (OCX) Peer Comparison – Compare with Others - valueresearchonline.com (Aug 31, 2026)
- Oncocyte Changes Name to Insight Molecular Diagnostics Inc. (iMDx), Moves Headquarters to Nashville - GlobeNewswire (Jun 17, 2025)
- Oncocyte Exits Irvine, Rebrands as Insight Molecular Diagnostics - Orange County Business Journal (Jun 17, 2025)
- OncoCyte Corp (OCX) Shareholding Pattern – Promoters, FIIs & DIIs - valueresearchonline.com (Aug 30, 2026)
- Determining immunotherapeutic responsiveness one test at a time - Nature (Sep 15, 2022)
- Oncocyte acquires Chronix Biomedical - MassDevice (Apr 19, 2021)
- Bio-Rad and Oncocyte Partner on Transplant Monitoring with Droplet Digital PCR - Clinical Lab Products (Apr 12, 2024)
Companies similar to OncoCyte Corp
- SN Genelab Private Limited · Biotechnology, Genetics, Health Care, Health Diagnostics
- Genoox · Biotechnology, Genetics, Health Care, Health Diagnostics
- Countable Labs · Biotechnology, Genetics, Health Care, Health Diagnostics
- Genetic Technologies Limited · Biotechnology, Genetics, Health Care, Health Diagnostics
- Noscendo GmbH · Biotechnology, Genetics, Health Care, Health Diagnostics
About OncoCyte Corp: questions and answers
What does OncoCyte Corp do?
Oncocyte™ is a precision diagnostics company with a mission to improve patient outcomes by providing personalized insights that inform critical decisions throughout the patient care journey.
Where is OncoCyte Corp headquartered?
OncoCyte Corp is headquartered in IRVINE, California, United States.
How many employees does OncoCyte Corp have?
OncoCyte Corp has about 56 employees.
Has OncoCyte Corp raised funding?
Yes. Fundz has recorded 5 funding events for OncoCyte Corp. The most recent, $21.7M, was in Feb 2025.
Who leads OncoCyte Corp?
Josh Riggs is a Chief Executive Officer at OncoCyte Corp.
What is the latest news on OncoCyte Corp?
On May 13, 2026, SEC 8-K (2.02): On May 13, 2026, Insight Molecular Diagnostics Inc. announced its financial results for the three months ended March 31, 2026. The press release outlines the company's performance metrics, including revenues and earnings figures for the first quarter, providing insights into the comp
Is OncoCyte Corp a public company?
Yes. OncoCyte Corp is publicly traded under the ticker IMDX.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy